WORX Quote, Financials, Valuation and Earnings

CVS Health has a net margin of -55.94% compared to SCWorx's net margin of 1.68%. SCWorx's return on equity of -80.46% beat CVS Health's return on equity of 6.12%.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand CVS Health has an analysts' consensus of $72.26 which suggests that it could grow by 13.51%. Given that CVS Health has higher upside potential than SCWorx, analysts believe CVS Health is more attractive than SCWorx.

SCWorx has a beta of 3.403, which suggesting that the stock is 240.336% more volatile than S&P 500. In comparison CVS Health has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.622%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health offers a yield of 4.18% to investors and pays a quarterly dividend of $0.67 per share. SCWorx pays -- of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

SCWorx quarterly revenues are $759.7K, which are smaller than CVS Health quarterly revenues of $97.7B. SCWorx's net income of -$425K is lower than CVS Health's net income of $1.6B. Notably, SCWorx's price-to-earnings ratio is -- while CVS Health's PE ratio is 17.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.37x versus 0.22x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.

First Physicians Capital Group has a net margin of -55.94% compared to SCWorx's net margin of --. SCWorx's return on equity of -80.46% beat First Physicians Capital Group's return on equity of --.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand First Physicians Capital Group has an analysts' consensus of -- which suggests that it could fall by --. Given that SCWorx has higher upside potential than First Physicians Capital Group, analysts believe SCWorx is more attractive than First Physicians Capital Group.

SCWorx has a beta of 3.403, which suggesting that the stock is 240.336% more volatile than S&P 500. In comparison First Physicians Capital Group has a beta of -12.023, suggesting its less volatile than the S&P 500 by 1302.307%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx pays -- of its earnings as a dividend. First Physicians Capital Group pays out -- of its earnings as a dividend.

SCWorx quarterly revenues are $759.7K, which are larger than First Physicians Capital Group quarterly revenues of --. SCWorx's net income of -$425K is higher than First Physicians Capital Group's net income of --. Notably, SCWorx's price-to-earnings ratio is -- while First Physicians Capital Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.37x versus 1.40x for First Physicians Capital Group. Usually stocks with elevated PS ratios are considered overvalued.

IQVIA Holdings has a net margin of -55.94% compared to SCWorx's net margin of 11.04%. SCWorx's return on equity of -80.46% beat IQVIA Holdings's return on equity of 21.32%.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand IQVIA Holdings has an analysts' consensus of $245.68 which suggests that it could grow by 58.04%. Given that IQVIA Holdings has higher upside potential than SCWorx, analysts believe IQVIA Holdings is more attractive than SCWorx.

SCWorx has a beta of 3.403, which suggesting that the stock is 240.336% more volatile than S&P 500. In comparison IQVIA Holdings has a beta of 1.459, suggesting its more volatile than the S&P 500 by 45.883%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx pays -- of its earnings as a dividend. IQVIA Holdings pays out -- of its earnings as a dividend.

SCWorx quarterly revenues are $759.7K, which are smaller than IQVIA Holdings quarterly revenues of $4B. SCWorx's net income of -$425K is lower than IQVIA Holdings's net income of $437M. Notably, SCWorx's price-to-earnings ratio is -- while IQVIA Holdings's PE ratio is 20.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.37x versus 1.84x for IQVIA Holdings. Usually stocks with elevated PS ratios are considered overvalued.

UNIVEC has a net margin of -55.94% compared to SCWorx's net margin of --. SCWorx's return on equity of -80.46% beat UNIVEC's return on equity of --.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that SCWorx has higher upside potential than UNIVEC, analysts believe SCWorx is more attractive than UNIVEC.

SCWorx has a beta of 3.403, which suggesting that the stock is 240.336% more volatile than S&P 500. In comparison UNIVEC has a beta of 0.149, suggesting its less volatile than the S&P 500 by 85.124%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx pays -- of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.

SCWorx quarterly revenues are $759.7K, which are larger than UNIVEC quarterly revenues of --. SCWorx's net income of -$425K is higher than UNIVEC's net income of --. Notably, SCWorx's price-to-earnings ratio is -- while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.37x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.